{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T11:40:07Z","timestamp":1743939607587,"version":"3.40.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,6]]},"DOI":"10.7759\/cureus.81786","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T11:11:35Z","timestamp":1743937895000},"source":"Crossref","is-referenced-by-count":0,"title":["Alcohol-Induced Neuroleptic Malignant Syndrome Complicated by Severe Acute Rhabdomyolysis"],"prefix":"10.7759","author":[{"given":"Juan R","family":"Santos-Rivera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina  J","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Izquierdo-Pretel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2007.164.6.870","article-title":"Neuroleptic malignant syndrome","volume":"164","author":"Strawn JR","year":"2007","unstructured":"Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry. 2007, 164:870-6. 10.1176\/ajp.2007.164.6.870","journal-title":"Am J Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/cc2978","article-title":"Bench-to-bedside review: rhabdomyolysis - an overview for clinicians","volume":"9","author":"Huerta-Alard\u00edn AL","year":"2005","unstructured":"Huerta-Alard\u00edn AL, Varon J, Marik PE. Bench-to-bedside review: rhabdomyolysis - an overview for clinicians. Crit Care. 2005, 9:158-69. 10.1186\/cc2978","journal-title":"Crit Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1314-5","article-title":"Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice","volume":"20","author":"Chavez LO","year":"2016","unstructured":"Chavez LO, Leon M, Einav S, Varon J. Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice. Crit Care. 2016, 20:135. 10.1186\/s13054-016-1314-5","journal-title":"Crit Care"},{"key":"ref4","article-title":"Rhabdomyolysis: pathogenesis, diagnosis, and treatment","volume":"15","author":"Torres PA","year":"2015","unstructured":"Torres PA, Helmstetter JA, Kaye AM, Kaye AD. Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Ochsner J. 2015, 15:58-69.","journal-title":"Ochsner J"},{"key":"ref5","article-title":"Rhabdomyolysis","author":"Stanley M","year":"2024","unstructured":"Stanley M, Chippa V, Aeddula NR. Rhabdomyolysis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158215","article-title":"Rhabdomyolysis-induced AKI (RIAKI) including the role of COVID-19","volume":"23","author":"M\u0142ynarska E","year":"2022","unstructured":"M\u0142ynarska E, Krzemi\u0144ska J, Wronka M, Franczyk B, Rysz J. Rhabdomyolysis-induced AKI (RIAKI) including the role of COVID-19. Int J Mol Sci. 2022, 23:8215. 10.3390\/ijms23158215","journal-title":"Int J Mol Sci"},{"key":"ref7","article-title":"Neuroleptic malignant syndrome","author":"Simon LV","year":"2024","unstructured":"Simon LV, Hashmi MF, Callahan AL. Neuroleptic malignant syndrome. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-007-0060-8","article-title":"Rhabdomyolysis","volume":"2","author":"Bagley WH","year":"2007","unstructured":"Bagley WH, Yang H, Shah KH. Rhabdomyolysis. Intern Emerg Med. 2007, 2:210-18. 10.1007\/s11739-007-0060-8","journal-title":"Intern Emerg Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2010.151","article-title":"Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features","volume":"48","author":"Cervellin G","year":"2010","unstructured":"Cervellin G, Comelli I, Lippi G. Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features. Clin Chem Lab Med. 2010, 48:749-56. 10.1515\/CCLM.2010.151","journal-title":"Clin Chem Lab Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2016","article-title":"Rhabdomyolysis","volume":"144","author":"Zimmerman JL","year":"2013","unstructured":"Zimmerman JL, Shen MC. Rhabdomyolysis. Chest. 2013, 144:1058-65. 10.1378\/chest.12-2016","journal-title":"Chest"},{"key":"ref11","article-title":"Neuroleptic malignant syndrome","volume":"24","author":"Caroff SN","year":"1988","unstructured":"Caroff SN, Mann SC. Neuroleptic malignant syndrome. Psychopharmacol Bull. 1988, 24:25-9.","journal-title":"Psychopharmacol Bull"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/01.ta.0000130761.78627.10","article-title":"Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference?","volume":"56","author":"Brown CV","year":"2004","unstructured":"Brown CV, Rhee P, Chan L, Evans K, Demetriades D, Velmahos GC. Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference?. J Trauma. 2004, 56:1191-6. 10.1097\/01.ta.0000130761.78627.10","journal-title":"J Trauma"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-45783-z","article-title":"The role of antipsychotics and other drugs on the development and progression of neuroleptic malignant syndrome","volume":"13","author":"Kyotani Y","year":"2023","unstructured":"Kyotani Y, Zhao J, Nakahira K, Yoshizumi M. The role of antipsychotics and other drugs on the development and progression of neuroleptic malignant syndrome. Sci Rep. 2023, 13:18459. 10.1038\/s41598-023-45783-z","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/335840-alcohol-induced-neuroleptic-malignant-syndrome-complicated-by-severe-acute-rhabdomyolysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T11:11:37Z","timestamp":1743937897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/335840-alcohol-induced-neuroleptic-malignant-syndrome-complicated-by-severe-acute-rhabdomyolysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,6]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.81786","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,6]]}}}